Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 13862 | 0.566 |
09:36 ET | 350 | 0.568 |
09:38 ET | 1904 | 0.5677 |
09:41 ET | 1560 | 0.5662 |
09:43 ET | 18983 | 0.56 |
09:48 ET | 147 | 0.5676 |
09:50 ET | 500 | 0.5601 |
09:52 ET | 891 | 0.5601 |
09:59 ET | 625 | 0.5601 |
10:03 ET | 13406 | 0.5509 |
10:06 ET | 200 | 0.56 |
10:08 ET | 1600 | 0.56 |
10:14 ET | 441 | 0.5561 |
10:15 ET | 287 | 0.5599 |
10:17 ET | 1000 | 0.56 |
10:21 ET | 316 | 0.56 |
10:28 ET | 1000 | 0.5522 |
10:30 ET | 3792 | 0.55379 |
10:33 ET | 1200 | 0.556 |
10:35 ET | 2166 | 0.556 |
10:42 ET | 5700 | 0.552 |
10:44 ET | 200 | 0.5525 |
10:46 ET | 5546 | 0.552 |
10:48 ET | 300 | 0.552 |
10:51 ET | 2000 | 0.55595 |
10:53 ET | 8000 | 0.552 |
11:00 ET | 1100 | 0.552 |
11:04 ET | 100 | 0.552 |
11:09 ET | 350 | 0.5566 |
11:15 ET | 2100 | 0.5596 |
11:20 ET | 500 | 0.5596 |
11:24 ET | 1300 | 0.552 |
11:27 ET | 5700 | 0.552 |
11:29 ET | 1100 | 0.5558 |
11:44 ET | 2890 | 0.5595 |
11:58 ET | 200 | 0.5576 |
12:05 ET | 750 | 0.5592 |
12:14 ET | 5400 | 0.559199 |
12:21 ET | 604 | 0.5558 |
12:23 ET | 1900 | 0.5619 |
12:43 ET | 700 | 0.56 |
12:56 ET | 200 | 0.5615 |
12:59 ET | 2308 | 0.56022 |
01:01 ET | 2000 | 0.5622 |
01:03 ET | 1658 | 0.5593 |
01:06 ET | 1460 | 0.5558 |
01:14 ET | 100 | 0.5621 |
01:39 ET | 4200 | 0.5619 |
01:46 ET | 1500 | 0.5618 |
01:48 ET | 3000 | 0.5614 |
02:20 ET | 200 | 0.5615 |
02:42 ET | 100 | 0.5599 |
02:44 ET | 133 | 0.5577 |
02:49 ET | 150 | 0.5555 |
02:54 ET | 260 | 0.5555 |
02:56 ET | 200 | 0.5598 |
03:02 ET | 400 | 0.5555 |
03:03 ET | 218 | 0.555542 |
03:34 ET | 600 | 0.5595 |
03:38 ET | 11618 | 0.5574 |
03:43 ET | 500 | 0.5565 |
03:45 ET | 100 | 0.5555 |
03:57 ET | 100 | 0.5574 |
03:59 ET | 6194 | 0.56 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 48.9M | -0.7x | --- |
Marker Therapeutics Inc | 48.4M | -3.9x | --- |
LAVA Therapeutics NV | 47.3M | -1.7x | --- |
Cue Biopharma Inc | 60.3M | -1.0x | --- |
Lipocine Inc | 44.1M | -4.5x | --- |
Palatin Technologies Inc | 31.5M | -0.8x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.9M |
---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.51 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.